Amarin Corp Plc (AMRN)

[smarterer]

Personally common sense tells me GIA is the the best for shareholders..BO is just the quickest..

Using your examples, it would also seem the GIA is best for those actually needing Vascepa to be widely and affordably available...which is the explicit business plan for Thero--and an approach which could well obviate the threat of generics even post-patent protections...